文献速递其他结缔组织病

胱抑素S:原发性干燥综合征下颌下腺受累严重程度的候选生物标志物

Cystatin S-a candidate biomarker for severity of submandibular gland involvement in Sjögren's syndrome.
PubMed 文献 · Rheumatology (Oxford) · 2017-01-01

结果显示pSS患者唾液胱抑素S显著降低,与刺激前唾液流率正相关,且在超声评分≥2者中进一步降低,miR-126和miR-335-5p表达与唾液流率呈反向关系,提示转录后调控。

要点

  • pSS患者唾液胱抑素S较健康志愿者显著降低(P=0.000)。
  • 胱抑素S与未刺激唾液流率正相关(r=0.75,P=0.01)。
  • 下颌下腺超声评分≥2者唾液胱抑素S显著降低。

核心结论

  • 胱抑素S是pSS的候选生物标志物,与腺体功能障碍强相关。
  • miR-126和miR-335-5p上调可能参与胱抑素S的表达调控。

研究设计与样本

  • 唾液胱抑素S采用无染色技术的蛋白质印迹法检测。
  • 在15例唇腺活检组织中用定量PCR检测miR-126、miR-335-5p和胱抑素S表达。

主要发现

  • pSS患者唾液胱抑素S较健康志愿者显著降低(P=0.000),在唾液分泌减少者中尤为明显。
  • 胱抑素S与未刺激唾液流率呈正相关(r=0.75,P=0.01)。
  • 下颌下腺超声评分≥2的患者唾液胱抑素S显著降低。
  • miR-126和miR-335-5p表达水平与未刺激唾液流率呈反向比例升高。
  • 胱抑素S的mRNA无显著变化,提示转录后调控。

关键数值与推荐

  • pSS患者与健康志愿者唾液胱抑素S比较P=0.000。
  • 胱抑素S与未刺激唾液流率相关系数r=0.75,P=0.01。
  • 下颌下腺超声评分≥2者唾液胱抑素S显著降低。

临床怎么用

  • 唾液胱抑素S或可作为评估pSS下颌下腺功能障碍严重程度的候选生物标志物。
  • miR-126和miR-335-5p可能成为调控胱抑素S表达的潜在靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Salivary cystatin S is a defence protein mainly produced by submandibular glands and involved in innate oral immunity. This study aimed to verify whether cystatin S was diversely expressed in different disease subsets of primary Sjogren's syndrome (pSS) patients, defined on the basis of salivary flow [unstimulated salivary flow rate (USFR)], minor salivary gland (MSG) focus score and submandibular gland ultrasonography abnormalities. We also evaluated miR-126 and miR-335-5p expression in MSG biopsies to verify whether an aberrant regulation of cystatin S at the glandular level may influence its salivary expression. METHODS: Forty pSS patients and 20 sex- and age-matched healthy volunteers were included. Salivary cystatin S levels were assessed by western blot analysis using a stain-free technology. The expression of miR-126, miR-335-5p and cystatin S was assessed by quantitative PCR in 15 MSG biopsies differing for USFR and MSG focus score. RESULTS: We found that salivary cystatin S was significantly decreased in pSS patients vs healthy volunteers ( P = 0.000), especially in those with hyposalivation. A positive correlation was observed between cystatin S and USFR ( r = 0.75, P = 0.01). Salivary cystatin S was also significantly reduced in patients with a submandibular gland ultrasonography score ⩾2. The expression levels of miR-126 and miR-335-5P increased in inverse proportion with USFR. The mRNA of cystatin S did not change significantly, suggesting post-transcriptional regulation. CONCLUSION: Cystatin S emerged as a promising biomarker for pSS, strongly correlated with glandular dysfunction. An upregulation of miR-126 and miR-335-5P might be implicated in its expression.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Martini D, Gallo A, Vella S, et al. Cystatin S-a candidate biomarker for severity of submandibular gland involvement in Sjögren's syndrome. Rheumatology (Oxford). 2017. PMID: 28339625. doi:10.1093/rheumatology/kew501

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。